GO
Loading...

Glaxo Wins FDA Approval for Allergy Spray

GlaxoSmithKline won U.S. approval for its Veramyst nasal spray to relieve seasonal and perennial allergies, a U.S. Food and Drug Administration spokeswoman said on Friday.

The drug is approved for use in adults and children two years of age and older, according to Kimberly Rawlings of the FDA.

Analysts have projected peak sales of up to $1 billion a year for the allergy treatment, which is chemically known as fluticasone furoate.

Contact U.S. News

  • CNBC NEWSLETTERS

    Get the best of CNBC in your inbox

    › Learn More

Don't Miss

U.S. Video

  • What is the DOJ planning to do with the money its getting from Bank of America's settlement? Tom Fitton, Judicial Watch President, says some of the money is going to liberal activist groups.

  • Discussing government contributions to GDP, which are slightly higher, with Jim Pethokoukis, American Enterprise Institute.

  • Shoppers at Ashley Furniture are getting $1 million in free stuff, after the owner in College Station, Texas, said it would reimburse anything bought last week if A&M Aggies beat South Carolina Gamecocks by more than 10 points. Mark Wilks, Ashley Furniture Store owner, says he's happy about the deal.